BUSINESS
-
Jul- 2025 -10 July
Turkiye bans Elon Musk’s AI chatbot Grok for offensive content
The chatbot, developed by Musk’s company xAI, posted vulgarities against Turkish President Recep Tayyip Erdogan, his late mother and personalities, while responding to users’ questions on the X Ankara: A Turkish court ordered Wednesday a ban on access to Elon Musk’s artificial intelligence chatbot Grok from Turkiye, after the platform allegedly disseminated content insulting to Turkey’s President and others. The chatbot, developed by Musk’s company xAI, posted vulgarities against Turkish President Recep Tayyip Erdogan, his late mother and personalities, while responding to users’ questions on the X social media platform, the pro-government A Haber news channel reported. Offensive responses were also directed toward modern Turkiye’s founder, Mustafa Kemal Atatürk, other media outlets said. That prompted the Ankara public to file for the imposition of restrictions…
Read More » -
10 July
Pak govt stepping up efforts to sell cash-strapped PIA
Pakistan plans to sell a majority stake in its debt-laden national airline, PIA, by end-2025 after a failed 2023 attempt. Four local firms have been pre-qualified for bidding, with the process expected to conclude in the year’s final quarter Islamabad: Pakistan’s government is firming up efforts to sell Pakistan International Airlines by the end of 2025, following a botched bid to sell the loss-making national flag-carrier last year, according to a media report on Wednesday. The Privatisation Commission board on Tuesday declared four local parties, including three associated with the cement business, eligible for bidding for the acquisition of the airline, The Express Tribune newspaper reported. In its previous attempt, the government had set the minimum price at Rs 85.03 billion…
Read More » -
10 July
Sensex, Nifty slip as investors turn cautious ahead of earnings and tariff concerns
Indian benchmark indices fell on Wednesday amid mixed global cues, tariff worries, and caution ahead of Q1 earnings. Sensex dropped 170 points while Nifty dipped 44. Brent crude eased, and FIIs turned net sellers while DIIs were net buyers. Mumbai: Equity benchmark indices Sensex and Nifty declined in early trade on Wednesday amid mixed global market trends as investors turned cautious due to tariff jitters and start of Q1 earnings season. The 30-share BSE Sensex fell 170.42 points to 83,542.09 in early trade. The 50-share NSE Nifty dipped 44.35 points to 25,478.15. From the Sensex firms, Larsen & Toubro, Tata Steel, ICICI Bank, HCL Tech, Infosys and Kotak Mahindra Bank were among the laggards. Hindustan Unilever, Asian Paints, Maruti and Titan were among…
Read More » -
10 July
Rupee drops 17 paise to 85.90 against dollar amid strong greenback, weak equities
The rupee weakened by 17 paise to 85.90 against the US dollar on Wednesday due to a stronger greenback and weak domestic equities. A dip in Brent crude prices helped limit further losses. FIIs sold Rs 26 crore worth of shares. Mumbai: The rupee declined 17 paise to 85.90 against the US dollar in early trade on Wednesday amid a strengthening greenback and subdued sentiments in the domestic equity markets. However, easing global crude oil prices, which had gone up overnight, capped steeper losses in the local unit, according to forex traders. At the interbank foreign exchange, the rupee opened at 85.84 against the greenback before slipping further to 85.90, down 17 paise from its previous close. The rupee rose 21 paise to…
Read More » -
9 July
Ola Electric rolls out MoveOS 5 for S1 scooters, Roadster X bikes
Ola Electric has begun rolling out its new MoveOS 5 software to S1 scooters and Roadster X bikes. The upgrade, delivered via OTA, promises better range, improved performance, and a more refined riding experience, especially on the Gen-3 platform New Delhi: Ola Electric on Tuesday said it is rolling out in-house developed MoveOS 5 software for both its S1 range of scooters and the recently launched Roadster X motorcycles. With the upgrade to MoveOS 5, the company has unlocked more potential of its product by offering enhanced performance, better reliability, and increased range, Ola Electric said in a statement. “MoveOS 5 is a reflection of our commitment to continuous innovation and product evolution, and it’s been engineered to deliver a riding…
Read More » -
9 July
Scindia, Cisco CEO discuss India’s digital future and 6G
Union Minister Jyotiraditya Scindia met Cisco CEO Chuck Robbins to discuss expanding the tech giant’s presence in India. They deliberated on AI, 6G, cybersecurity, and inclusive growth, building on Cisco’s Chennai facility and India’s emerging role as a digital leader New Delhi: Union Communications Minister Jyotiraditya Scindia on Tuesday met Cisco CEO Chuck Robbins and his team here, encouraging them to deepen their footprint in India’s rapidly evolving digital technology landscape and growing market. During the meeting, the minister highlighted the importance of leveraging the country’s vast potential and vibrant talent pool. Underscoring the importance of building solutions that uplift the common man, he stressed Bharat’s pivotal role in driving the 6G revolution and India’s growing momentum in artificial intelligence (AI).…
Read More » -
9 July
Indian textile stocks rally as Trump slaps 35 per cent tariff on Bangladesh
Indian textile stocks surged after US President Donald Trump imposed a 35 per cent tariff on Bangladeshi goods. Companies like Gokaldas Exports and Vardhman Textiles saw gains. The US warned of further action if Bangladesh retaliates with higher tariffs. New Delhi:The Indian textile companies saw their shares surging in the morning trade on Tuesday after the US President Donald Trump slapped 35 per cent tariff on Bangladesh. Shares of textile firms such as Trident, Welspun, Gokaldas Exports, KPR Mill, Vardhman Textiles and Arvind Ltd. went up in the early trade. The stock of Gokaldas Exports were up more than 7 per cent while Vardhman Textiles shares rallied 7.4 per cent and Welspun Living’s stock jumped two per cent. In a…
Read More » -
9 July
Realme ropes in Vicky Kaushal as brand ambassador for smartphones
Smartphone brand realme has appointed actor Vicky Kaushal as its brand ambassador ahead of the July 24 launch of the realme 15 Series New Delhi: Smartphone company realme has appointed actor Vicky Kaushal as its brand ambassador for smartphones, the company said on Tuesday. The company will launch realme 15 Series smartphones on July 24 with a campaign led by Kaushal. “As we gear up to launch the realme 15 Series on July 24, this partnership marks an exciting step forward in building realme’s emotional and cultural connection with its audience,” realme India Chief Marketing Officer Francis Wong said. Realme is among the top 5 brands in volume sales in India. The company had 11 per cent market share in the…
Read More » -
8 July
Sebi Chairman says, no other market risk like Jane Street case
Sebi Chairman Tuhin Kanta Pandey said the regulator does not see widespread risks similar to the Jane Street manipulation case. SEBI is planning to enhance surveillance after impounding over Rs 4,843 crore from the hedge fund for index manipulation Mumbai: Sebi Chairman Tuhin Kanta Pandey on Monday said the capital markets regulator does not see “many other risks” like the manipulations done by the hedge fund Jane Street. Speaking to reporters days after a Sebi order pointed towards gains of over Rs 4,800 crore made by Jane Street, Pandey said Sebi is mulling upgrading its surveillance systems. “And I don’t think there are very many other risks,” Pandey said, replying to a specific question on whether there are other funds or…
Read More » -
8 July
Biocon Biologics gets UK’s MHRA approval for Denosumab biosimilars
The company also secured European Commission authorisation, enabling the launch across the EU and EEA regions New Delhi: Biocon Ltd on Monday said its arm Biocon Biologics Ltd has received marketing authorisations from the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK for Vevzuo and Evfraxy, biosimilars of Denosumab used in the treatment of bone-related diseases. Vevzuo is authorised for the prevention of skeletal-related events (pathological fracture, radiation to bone, spinal cord compression or surgery to bone) in adults with advanced malignancies involving bone, Biocon said in a regulatory filing. It is also authorised for the treatment of adults and skeletally mature adolescents with giant cell tumour of bone that is unresectable or where surgical resection is likely to result in…
Read More »